Representative before the EPO

Employment test 11 - 50 employees
Company dna df mp
operating since 2000
Headquarter in Munich
active in Legal Services and IP Consulting

Hans Ulrich Dörries has worked on the following 74 EPO patent applications which have been published in the last five years:

EP11719802

LIPIDOMIC BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE

IPC classification:
G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP11804309

SYSTEMS AND METHODS FOR MAGNETIZED STENT HAVING GROWTH-PROMOTING PROPERTIES

IPC classification:
A61F 2/82
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP11752152

CONCENTRATE FOR MEDICAL SOLUTIONS, PRODUCTION THEREOF AND USE THEREOF IN DIALYSIS

IPC classification:
A61K 9/00, A61K 33/06, A61K 33/10
Applicant:
Fresenius Medical Care Deutschland GmbH
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12188326

Human c-fms antigen binding proteins

IPC classification:
A61K 39/395, A61P 35/00, C07K 14/715, C07K 16/28
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP11186984

Cover for a valve cap of a gas cylinder

IPC classification:
A61M 16/10, A61M 16/20, F17C 13/00, F17C 13/06
Applicant:
Linde AG
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP11714028

BIOMARKERS FOR SENSITIVE DETECTION OF STATIN-INDUCED MUSCLE TOXICITY

IPC classification:
G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12722044

METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS

IPC classification:
A61K 39/395, A61P 3/06, C07K 16/40
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12706985

AMINOINDANE COMPOUNDS AND USE THEREOF IN TREATING PAIN

IPC classification:
A61K 31/452, A61P 23/02, A61P 29/02, C07D 207/09, C07D 211/26, C07D 401/12, C07D 405/12, C07D 417/12, C07D 471/10, C07D 498/10
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12188330

Human c-fms antigen binding proteins

IPC classification:
A61K 39/395, A61P 35/00, C07K 14/715, C07K 16/28
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11825842

METHODS OF TREATING AUTOIMMUNE DISEASES WITH ANTI-FCERI ANTIBODIES

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/28
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP11188325

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment

IPC classification:
G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11188328

Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment

IPC classification:
G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12168126

Device for filling gas cylinders with gas under pressure and filling station

IPC classification:
F17C 5/00, F17C 7/00
Applicant:
Linde AG
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP12766369

USE OF C-MET PROTEIN FOR PREDICTING THE EFFICACY OF ANTI-HEPATOCYTE GROWTH FACTOR ("HGF") ANTIBODIES IN ESOPHAGEAL AND GASTRIC CANCER PATIENTS

IPC classification:
A61K 39/395, G01N 33/574, G01N 33/68
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12766802

PRE-PROGRAMMED NON-FEEDBACK CONTROLLED CONTINUOUS FEEDING OF CELL CULTURES

IPC classification:
C12M 3/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12842087

DETECTION UNITS AND METHODS FOR DETECTING A TARGET ANALYTE

IPC classification:
G01N 21/00, G01N 33/48
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12848112

TREATMENT OF RED BLOOD CELLS

IPC classification:
A61K 35/18, A61M 1/36
Applicant:
The General Hospital Corporation
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP12852514

PERCUTANEOUS VALVE REPLACEMENT DEVICES

IPC classification:
A61F 2/24
Applicant:
The Trustees of The University of Pennsylvania
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13178927

Antigen binding proteins capable of binding thymic stromal lymphopoietin

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12815893

FLOCCULATION METHOD

IPC classification:
C07K 1/30, C12N 5/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12795979

METHODS OF TREATMENT USING AN ANTIBODY AGAINST INTERFERON GAMMA

IPC classification:
C07K 16/24, C12Q 1/68, G01N 33/68
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP12857335

FIBER OPTIC FLOW AND OXYGENATION MONITORING USING DIFFUSE CORRELATION AND REFLECTANCE

IPC classification:
A61B 5/145
Applicant:
The Trustees of The University of Pennsylvania
Applicant:
The Research Foundation for The State University of New York
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12859237

PLATFORMS FOR MITRAL VALVE REPLACEMENT

IPC classification:
A61F 2/24
Applicant:
The Trustees of The University of Pennsylvania
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12808642

VARIANT FC-POLYPEPTIDES WITH ENHANCED BINDING TO THE NEONATAL FC RECEPTOR

IPC classification:
C07K 16/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13185218

Polymeric stent

IPC classification:
A61F 2/91
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13735764

PURIFICATION OF HERPES VIRUS

IPC classification:
B01D 15/00, C12N 7/00, C12N 7/02
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12188904

Improved method of mapping glycans of glycoproteins

IPC classification:
G01N 33/68
Applicant:
Hexal AG
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13758116

SUPERABSORBENT COATED STENTS FOR VASCULAR REDUCTION AND FOR ANCHORING VALVE REPLACEMENTS

IPC classification:
A61F 2/24, A61F 2/95
Applicant:
The Trustees of The University of Pennsylvania
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13724077

STABLE FORMULATIONS CONTAINING ANTI-PCSK9 ANTIBODIES

IPC classification:
A61K 38/00, A61K 39/395, A61P 3/06, C07K 16/40
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP12171291

GLP-1 compounds

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION WITHDRAWN
EP13816586

INFRARED ILLUMINATED AIRWAY MANAGEMENT DEVICES AND KITS AND METHODS FOR USING THE SAME

IPC classification:
A61B 1/00, A61B 1/05, A61B 1/06, A61B 17/3209, A61F 7/00, A61M 16/04
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP12171292

GLP-1 compounds

IPC classification:
A61K 38/26, C07K 14/605
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13742802

HUMAN BTNL3 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF

IPC classification:
A61K 38/17, A61K 39/395, C07K 14/705, C07K 19/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13826076

COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE

IPC classification:
A21D 2/00
Applicant:
Aquarius Biotechnologies, Inc.
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13756909

LIPID ASSEMBLIES COMPRISING ANIONIC LYSOLIPIDS AND USE THEREOF

IPC classification:
A61K 9/127
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
PATENT GRANTED
EP13843995

NOVEL COMPOUNDS, THEIR PREPARATION AND THEIR USES

IPC classification:
A61K 31/506, A61P 31/12, A61P 35/00, C07D 401/14
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP13853466

COLLAGEN IV BINDING ASSAY FOR THE DETECTION OF COLLAGEN VII

IPC classification:
G01N 33/53
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP15156017

BTNL9 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF

IPC classification:
A61K 38/00, A61K 38/17, A61K 39/395, C07K 14/705, C07K 16/18, C12N 5/00, C12N 15/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP13868964

ADMINISTRATION OF RECOMBINANT COLLAGEN 7 FOR THE TREATMENT OF AGE RELATED DISORDERS

IPC classification:
A01N 63/00, A61K 38/39, A61K 47/48
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP15168204

OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/46
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14708309

NON-HIGH DENSITY LIPOPROTEIN DERIVED CVD MARKERS

IPC classification:
G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14708465

METHODS FOR TREATING CROHN'S DISEASE USING AN ANTI-IL23 ANTIBODY

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/24
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14714521

METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS

IPC classification:
C07K 16/00, C12N 1/38, C12N 5/00, C12P 21/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14711352

METHODS FOR TREATING PSORIASIS USING AN ANTI-IL-23 ANTIBODY

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/24
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14714890

REMOVAL OF LEAKED AFFINITY PURIFICATION LIGAND

IPC classification:
B01D 15/36, C07K 1/18, C07K 1/22, C07K 14/705, C07K 14/715, C07K 16/00, C07K 16/06
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14775634

RIBOTOXIN MOLECULES DERIVED FROM SARCIN AND OTHER RELATED FUNGAL RIBOTOXINS

IPC classification:
C12P 21/00
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14177705

Improved method of mapping glycans of glycoproteins in serum samples

IPC classification:
G01N 33/50
Applicant:
Hexal AG
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP15171666

BIOMARKERS FOR SENSITIVE DETECTION OF STATIN-INDUCED MUSCLE TOXICITY

IPC classification:
G01N 33/68, G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP11726371

SKELETAL MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS

IPC classification:
A61K 35/28, A61K 48/00, A61P 21/00, C12N 5/0775
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13737090

METHODS FOR TREATING HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

IPC classification:
A61K 39/395, A61P 3/06, C07K 16/40
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP15184078

ANTIBODIES AGAINST HUMAN IL-22 AND USES THEREFOR

IPC classification:
C07K 14/54, C07K 16/24
Applicant:
MedImmune Limited
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION IN PROGRESS
EP14199893

Sequence variants

IPC classification:
C12N 15/09
Applicant:
Sandoz AG
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
PATENT GRANTED
EP12199416

Copolymers containing phosphorylcholine groups and methods of preparing and using the same

IPC classification:
C08F 2/38, C08F 220/18, C08F 230/02, C08F 230/04
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11748824

DIPEPTIDES TO ENHANCE YIELD AND VIABILITY FROM CELL CULTURES

IPC classification:
C07K 5/06, C12N 5/00, C12N 5/10
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
PATENT GRANTED
EP11715365

BTNL9 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF

IPC classification:
A61K 38/17, A61K 39/395, C07K 14/705, C12N 5/00, C12N 15/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11730426

ADHERENT STROMAL CELLS DERIVED FROM PLANCENTAS OF MULTIPLE DONORS AND USES THEREOF

IPC classification:
C12N 5/073
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12169517

Sensitive efficacy and specificity biomarkers for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition

IPC classification:
G01N 33/92
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14864626

METHODS OF TREATING ALLERGIES AND AUTOIMMUNE DISEASES WITH HOMOGENATE OF AXENIC C. ELEGANS

IPC classification:
A61K 35/12, A61K 39/00
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14870178

HUMAN HERPESVIRUS TRIMERIC GLYCOPROTEIN B, PROTEIN COMPLEXES COMPRISING TRIMERIC GB AND THEIR USE AS VACCINES

IPC classification:
A61K 39/245, C07K 14/03, C07K 14/045
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14877549

PROSTATE CANCER GENE PROFILES AND METHODS OF USING THE SAME

IPC classification:
G01N 33/574
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14821424

OVEREXPRESSION OF N-GLYCOSYLATION PATHWAY REGULATORS TO MODULATE GLYCOSYLATION OF RECOMBINANT PROTEINS

IPC classification:
C12N 9/10, C12N 15/85, C12P 21/00
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15720820

BISPECIFIC ANTIBODIES THAT BIND TO CD38 AND CD3

IPC classification:
C07K 16/28, C07K 16/30, C07K 16/46
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14889100

METHOD FOR THE QUANTIFICATION OF PARASITE EGGS IN FECES

IPC classification:
B01D 35/00, C12Q 1/24, G01N 33/53
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15772401

PRODUCING THERAPEUTIC PROTEINS

IPC classification:
A01K 43/04, A01K 67/027, G06F 7/00
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP15727150

ASSAY FOR DETECTING TH1 AND TH2 CELL POPULATIONS

IPC classification:
G01N 33/533
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP16199576

HUMAN IL-23 ANTIGEN BINDING PROTEINS

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
APPLICATION PUBLISHED
EP16203195

METHODS OF TREATMENT USING AN ANTIBODY AGAINST INTERFERON GAMMA

IPC classification:
C07K 16/24, C12Q 1/68, G01N 33/68
Applicant:
Amgen Inc
Agent:
Hans Ulrich Dörries, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
The application has been published

Please Sign in to use this feature